COVID-19 Switzerland
Information on the current situation, as of 2 December 2021
Epidemiological course,Switzerland and Liechtenstein
Tests and share of positive tests
The number of positive tests may be higher than the number of newly confirmed cases due to some people being tested more than once.
Please note: There is no data available by canton or age group for the laboratory tests conducted before week 21.
PCR tests detect the SARS-CoV-2 virus’s genetic material whereas rapid antigen tests detect specific proteins. Both tests are done with a nose and throat swab.
Geographical distribution
Number of tests, Switzerland and Liechtenstein, 15.02.2021 to 01.12.2021, Per 100 000 inhabitants
Please note: There is no data available by canton or age group for the laboratory tests conducted before week 21. Rapid antigen tests have only been carried out since 02.11.2020.
Switzerland and Liechtenstein
- Tests / 100 000 inh.
- 94 601,15
- Share of positive PCR tests
- 8,9%
- Share of positive rapid antigen tests
- 2,8%
Development over time: number of tests
Number of tests, Switzerland and Liechtenstein, 15.02.2021 to 01.12.2021, Per 100 000 inhabitants
Please note: There is no data available by canton or age group for the laboratory tests conducted before week 21. Rapid antigen tests have only been carried out since 02.11.2020.
Development over time: share of positive tests
Share of positive tests, Switzerland and Liechtenstein, 15.02.2021 to 01.12.2021
Please note: There is no data available by canton or age group for the laboratory tests conducted before week 21. Rapid antigen tests have only been carried out since 02.11.2020.
Demography
Number of tests, Switzerland and Liechtenstein, 15.02.2021 to 28.11.2021, Per 100 000 inhabitants
Please note: There is no data available by canton or age group for the laboratory tests conducted before week 21. Rapid antigen tests have only been carried out since 02.11.2020.